These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 18753829

  • 1. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Pichardo-Romero PA.
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [Abstract] [Full Text] [Related]

  • 2. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 3. Biokinetics and dosimetry in patients of 99mTc-EDDA/HYNIC-Tyr3-octreotide prepared from lyophilized kits.
    González-Vázquez A, Ferro-Flores G, Arteaga de Murphy C, Gutiérrez-García Z.
    Appl Radiat Isot; 2006 Jul; 64(7):792-7. PubMed ID: 16542847
    [Abstract] [Full Text] [Related]

  • 4. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.
    Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
    [Abstract] [Full Text] [Related]

  • 5. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A, Perera-Pintado A, Prats-Capote A, Batista-Cuellar JF, Casacó-Santana C.
    Rev Esp Med Nucl Imagen Mol; 2012 Apr; 31(2):61-5. PubMed ID: 22305264
    [Abstract] [Full Text] [Related]

  • 6. 99mTc-exendin(9-39)/octreotide: biokinetics and radiation dosimetry in healthy individuals.
    Ocampo-García BE, Santos-Cuevas CL, Luna-Gutiérrez MA, Ignacio-Alvarez E, Pedraza-López M, Manzano-Mayoral C.
    Nucl Med Commun; 2017 Nov; 38(11):912-918. PubMed ID: 28953210
    [Abstract] [Full Text] [Related]

  • 7. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients.
    Santos-Cuevas C, Davanzo J, Ferro-Flores G, García-Pérez FO, Ocampo-García B, Ignacio-Alvarez E, Gómez-Argumosa E, Pedraza-López M.
    Nucl Med Biol; 2017 Sep 22; 52():1-6. PubMed ID: 28575794
    [Abstract] [Full Text] [Related]

  • 9. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
    Mendoza-Sánchez AN, Ferro-Flores G, Ocampo-García BE, Morales-Avila E, de M Ramírez F, De León-Rodríguez LM, Santos-Cuevas CL, Medina LA, Rojas-Calderón EL, Camacho-López MA.
    J Biomed Nanotechnol; 2010 Aug 22; 6(4):375-84. PubMed ID: 21323111
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
    Van de Wiele C, Dumont F, Dierckx RA, Peers SH, Thornback JR, Slegers G, Thierens H.
    J Nucl Med; 2001 Nov 22; 42(11):1722-7. PubMed ID: 11696645
    [Abstract] [Full Text] [Related]

  • 12. 99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells: kinetics, dosimetry and effect on cellular proliferation.
    Santos-Cuevas CL, Ferro-Flores G, Rojas-Calderón EL, García-Becerra R, Ordaz-Rosado D, Arteaga de Murphy C, Pedraza-López M.
    Nucl Med Commun; 2011 Apr 22; 32(4):303-13. PubMed ID: 21304415
    [Abstract] [Full Text] [Related]

  • 13.
    Cheng KT, Ferro-Flores G, Arteaga de Murphy C.
    ; 2004 Apr 22. PubMed ID: 20641296
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
    Okarvi SM, al-Jammaz I.
    Anticancer Res; 2003 Apr 22; 23(3B):2745-50. PubMed ID: 12894569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM, Al Jammaz I.
    Nucl Med Biol; 2010 Apr 22; 37(3):277-88. PubMed ID: 20346867
    [Abstract] [Full Text] [Related]

  • 17. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May 22; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.
    J Nucl Med; 2006 Mar 22; 47(3):492-501. PubMed ID: 16513619
    [Abstract] [Full Text] [Related]

  • 20. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K.
    J Nucl Med; 2003 Jun 22; 44(6):947-52. PubMed ID: 12791824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.